Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
ResMed CEO Mick Farrell has highlighted the significant impact of wearables and GLP-1s on the sales of sleep apnea devices. He referred to these innovations as 'two tidal waves' driving more people to ResMed’s products. ResMed, a leading CPAP device maker, has seen its stock surge, with expectations for further gains. The company is set to release its Q1 FY25 earnings on October 24, 2024, following the closing of the NYSE, with a webcast available for the announcement.
CEO Mick Farrell sees the ‘two tidal waves’ of innovation driving more people to @ResMed’s devices https://t.co/VeBDpuD1S0
ResMed will be releasing its Q1 FY25 earnings on October 24, 2024, following the closing of the NYSE. A webcast will also be available to follow the announcement. #ResMed #Q1FY25 #earnings #NYSE $RMD $BKX
ResMed Stock Is Surging. Expect More Gains for the Medical Equipment Maker. https://t.co/uOQVXLDZVv